Avenue Therapeutics, Inc. (NASDAQ:ATXI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an ...
LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing next-generation programmed T cell therapies ...
Ahead of the Paddy Power World Darts Championship, Olympic legend teams up with Paddy Power and Prostate Cancer UK to save ...
Trump Treasury Pick Is Poised to Test ‘Three Arrows’ Economic Strategy Scott Bessent’s “3-3-3” plan to stimulate growth, reduce the deficit and expand oil production will soon face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback